Market Overview

Morgan Stanley Sees Good Things Ahead for Surgical Care Affiliates

Share:

In a report published Friday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on Surgical Care Affiliates (NASDAQ: SCAI).

In the report, Morgan Stanley noted, “SCAI issued 2014 Adjusted EBITDA-NCI guidance of $154M to $158M, which was in-line with MS and consensus at $154M and $155M, respectively. Guidance is adjusted for the adverse impact of weather on 1Q performance. We view initial guidance as achievable, as SCA should drive growth through accelerating contributions from its health system partnerships and consolidation. Specifically, we model $82M and $5.9M in acquisition revenue from SCA's consolidated and non-consolidated facilities, respectively in 2014.”

Surgical Care Affiliates closed on Thursday at $30.73.

Latest Ratings for SCAI

DateFirmActionFromTo
Jan 2017Initiates Coverage OnNeutral
Jun 2016DowngradesBuyNeutral
Feb 2016MaintainsBuy

View More Analyst Ratings for SCAI
View the Latest Analyst Ratings

Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Reiteration Analyst Ratings

 

Related Articles (SCAI)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
SPLKMaintains150.0
HEBDowngrades
CHHInitiates Coverage On97.0
PSTGUpgrades
SPLKMaintains150.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Morgan Stanley Sees Near-Term Transitions, Long-Term Opportunities for AVG Technologies NV

UPDATE: Morgan Stanley Reiterates on Pfizer as Vaccine Pipeline is Under-Appreciated